Mr. Gerstein graduated from Brooklyn Law School with honors in 1977. For the six years prior to joining Garwin & Bronzaft in January 1978, he was an investigatory accountant specializing in the area of stockholder's derivative and class action. Mr. Gerstein is recognized as a leading attorney in complex litigation around the country resolving successfully antitrust, securities and consumer related class actions resulting in hundreds of millions of dollars for class members. Most recently, he was principally responsible for the negotiation of settlement of $110 million (Cardizem), $220 million (Buspar) and $175 million (Relafen) representing direct purchasers of pharmaceutical products.

He has been named lead counsel in federal and state courts across the United States. He has lectured recently at conferences discussing important cutting edge antitrust issues in Florida and California.

Mr. Gerstein is admitted to practice in all Courts of the State of New York and the Court of Appeals for the Second, Third, Fifth, Seventh, Ninth, and Eleventh Circuits. He is a member of the Association of the Bar of the City of New York and the New York County Lawyers Association (the "NYCLA"), the Federal Bar Council and a member of the Federal Courts Committee of the NYCLA.